In vitro inhibition of human polymorphonuclear cell function by cloricromene

Area of Science:

• Pharmacology
• Cell Biology
• Immunology

Background:

• Polymorphonuclear cells (PMNs) play a critical role in inflammatory and immune responses.
• Dysregulated PMN activity contributes to various pathophysiological conditions.
• Coumarin derivatives are known for their diverse biological properties.

Purpose of the Study:

• To investigate the in vitro effects of Cloricromene on key polymorphonuclear cell (PMN) functions.
• To assess Cloricromene's impact on PMN adhesion, superoxide anion generation, and chemotaxis.
• To evaluate the biological activity of Cloricromene's major metabolite.

Main Methods:

• In vitro assays using cultured human umbilical vein endothelial cells (EC) and PMNs.
• Measurement of PMN adhesion to EC (untreated and IL-1 activated).
• Assessment of PMN superoxide generation induced by TPA or FMLP.
• Evaluation of PMN and monocyte chemotaxis using a modified Boyden chamber technique.
• High-Performance Liquid Chromatography (HPLC) for drug uptake studies.

Main Results:

• Cloricromene demonstrated dose-dependent inhibition of PMN adhesion to both untreated and IL-1 activated EC.
• Cloricromene significantly inhibited PMN superoxide generation induced by TPA and FMLP.
• Cloricromene concentration-dependently inhibited PMN and monocyte chemotaxis induced by FMLP.
• The major metabolite, cloricromene acid, showed no significant biological activity up to 500 microM.
• Cloricromene rapidly accumulated in PMNs, with sustained levels observed over 60 minutes.

Conclusions:

• Cloricromene effectively inhibits multiple in vitro PMN activities, including adhesion, superoxide generation, and chemotaxis.
• The observed inhibitory effects of Cloricromene on PMN functions suggest potential pharmacological applications.
• Cloricromene's efficacy is likely mediated by the parent compound, as its major metabolite lacks significant biological activity.